Medication info
Simvastatin 20mg Tablets

Simvastatin 20mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Ixu Pharmaceutical Co., Ltd.
Appearance
Brownish yellow oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201901722 · Approved 2019.03.22 · Insurance code 658502110

Summary

Main use
Improvement of hyperlipidemia; improvement of familial hypercholesterolemia in children; prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events because of coronary heart disease, diabetes, peripheral vascular disease, or a history of stroke or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate based on the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). 2) For the recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), see below (see Precautions for Use, 6. Drug Interactions). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. This medicine should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In older adults, a maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see Precautions for Use, 2. Contraindications) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Use in patients with renal impairment Since this medicine is not substantially excreted by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, treatment should be initiated at 5 mg daily, with careful monitoring.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. The dose should be individually adjusted according to the recommended treatment goal. Dose adjustments should be made at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Ixu Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; improvement of familial hypercholesterolemia in children; prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • hyperlipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • primary dysbetalipoproteinemia
  • hypertriglyceridemia
  • secondary hyperlipidemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication helps to reduce hyperlipidemia and the risk of cardiovascular disease. It is particularly used in adults with a history of coronary heart disease, diabetes, peripheral vascular disease, or cerebral vascular disease to reduce the risk of coronary events, myocardial infarction, stroke, and vascular revascularization. It also helps lower cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia and increases levels of good cholesterol (HDL). In children, it is used as an adjunct to effectively lower cholesterol levels when dietary management alone is insufficient for familial hypercholesterolemia. Overall, this medicine is used to improve heart health and reduce the risk of vascular diseases.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events because of coronary heart disease, diabetes, peripheral vascular disease, or a history of stroke or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate based on the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). 2) For the recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), see below (see Precautions for Use, 6. Drug Interactions). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. This medicine should be used in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In older adults, a maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see Precautions for Use, 2. Contraindications) and fenofibrate), the dose of this medicine must not exceed 10 mg daily. (6) Use in patients with renal impairment Since this medicine is not substantially excreted by the kidneys, dose adjustment is not necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, treatment should be initiated at 5 mg daily, with careful monitoring.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended starting dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. The dose should be individually adjusted according to the recommended treatment goal. Dose adjustments should be made at intervals of 4 weeks or longer.

Precautions

This medication is used to lower cholesterol levels in the blood. Caution is advised while taking this medication as there is a risk of muscle-related issues. Especially when taking high doses or concomitant medications, serious muscle damage such as myopathy or rhabdomyolysis may occur. If symptoms such as muscle pain, weakness, or tenderness occur, consultation with a doctor is essential. Additionally, this medication may impact liver function, so patients with liver disease or elevated liver enzymes should not take it. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. It may interact with specific antifungals, antibiotics, and immunosuppressants, increasing the risk of side effects; therefore, it is essential to inform the doctor about any other medications being taken. Elderly patients and women are at a higher risk of developing myopathy, and extra caution is advised during usage. Regular blood tests for monitoring liver function and muscle status are recommended while on this medication. In case of overdose, seek immediate hospital care for appropriate treatment. Lastly, this medication should be kept out of reach of children and should be stored in its original container.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 96 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes mellitus
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • extraocular muscle movement disorder
  • facial paresis
  • tremor
  • sensory disturbances
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • depression
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • cholestasis jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant liver necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • drug rash resembling lichen planus
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • sensory numbness of the limbs
  • tingling sensation
  • cold sensation
  • sensory impairment
  • muscle weakness
  • thrombocytopenia
  • interstitial lung disease
  • memory decline
  • forgetfulness
  • amnesia
  • memory disorders
  • confusion
  • vomiting
  • mucous stools

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is safe to store at room temperature between 1°C and 30°C. Therefore, it should be kept in a cool and dry place until use, avoiding direct sunlight or high temperatures.

Appearance and packaging

Appearance

Brownish yellow oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.